Ubiquitination-based Classification and a Prognostic Signature Identify the Role of TRIM21 in Sarcoma Progression
The classification and signature stratify sarcoma patients for prognosis and immunotherapy response, with TRIM21 representing a promising therapeutic target.
Authors
- Zhiqiang Cao (ORCID: https://orcid.org/0009-0002-4585-8337)
- Yibo Gao (ORCID: https://orcid.org/0000-0003-3060-2259)
- Jinhui Liu (ORCID: https://orcid.org/0000-0001-8032-5099)
- Weihao Lin (ORCID: https://orcid.org/0009-0009-1894-7626)
- Zhentao Yu (ORCID: https://orcid.org/0000-0003-1349-6546)
- Lin Zhang
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- National Cancer Center (US)
- Nanfang Hospital (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Current Medicinal Chemistry
- Published
- 2026-01-15
- DOI
- https://doi.org/10.2174/0109298673388379251113061745
- Primary Topic
- interferon and immune responses
- Type
- article
- Field-Weighted Citation Impact
- 0.00